Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Maintenance Chemotherapy in Advanced Ovarian Cancer: Yes or No?
Link ID 31391
Title Maintenance Chemotherapy in Advanced Ovarian Cancer: Yes or No?
Url http://www.medscape.com/viewarticle/733397?src=rss
Description Dr. Maurie Markman reports on a meta-analysis that indicates continued chemotherapy after complete response to primary therapy may prove beneficial in patients with advanced ovarian cancer. Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Dec 3, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. What Happens When B Cells Go Awry?
  In this video blog, Dr. Richard Stone reports on 2 recent papers that shed light on the identification, progression, and prognosis of B-cell malignancies such as CLL and ALL.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. Does Switch Maintenance Benefit Patients With NSCLC?
  In patients with partial response to initial therapy, is there benefit to switching to a new agent for maintenance therapy? Dr. Mark Kris examines studies that address this question. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. Contribution of Platelets to Tumour Metastasis
  Platelets guard tumour cells from immune elimination and promote their arrest at the endothelium, supporting the establishment of secondary lesions. Nature Reviews Cancer
Category:   Articles > Hematology-Oncology


4. ASCO 2009: Expert Video Perspective on Multiple Myeloma
  In this video highlight, Dr. Sagar Lonial shares his thoughts on the latest advances in multiple myeloma research from the 2009 ASCO annual meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Aspirin Use May Reduce Mortality in Prostate Cancer
  Anticoagulants, especially aspirin, reduced disease-specific mortality risk in prostate cancer patients. The effect was greatest in the highest-risk patients. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS